万维提示：
1、投稿方式：在线投稿。
2、期刊网址：https://academic.oup.com/scan
3、投稿网址：https://mc.manuscriptcentral.com/scan
4、官网邮箱：lieber@ucla.edu（主编）
5、官网电话：+1 310 206 4050（主编）
6、期刊刊期：月刊，一个月出版一期。
2021年1月15日星期五
投稿须知
【官网信息】
Instructions to Authors
Please note that this journal is fully open access. All articles are subject to an Article Processing Charge (APC) if they are accepted for subsequent publication. For more information about Open Access licences and charges, see open access options for authors.
All manuscripts must be submitted online. Once you have prepared your manuscript according to the instructions below please visit the online submission web site. Instructions on submitting your manuscript online can be viewed on our Submitting Your Manuscript page.
You can pay Open Access charges using our Author Services site. This will enable you to pay online with a credit/debit card, or request an invoice by email or post.
SCAN is a fully open access journal, and all articles are published in the journal under an open access licence immediately upon publication. You will need to pay an open access charge to publish under an open access licence.
Details of the open access licences and open access charges.
CC BY, CC BY-NC, CC BY-NC-ND licence - £1250 / $1995 / €1700
If the corresponding author is based in one of the countries included in our Developing Countries Initiative, your article will be eligible for a full waiver of the open access charge.
OUP has a growing number of Read and Publish agreements with institutions and consortia which provide funding for open access publishing. This means authors from participating institutions can publish open access, and the institution may pay the charge. Find out if your institution is participating.
Orders from the UK will be subject to a 20% VAT charge. For orders from the rest of the European Union, OUP will assume that the service is provided for business purposes. Please provide a VAT number for yourself or your institution and ensure you account for your own local VAT correctly.
Resources
A growing number of universities, government agencies and funding organizations maintain funds to assist researchers with open-access publication fees (we have a list of these organisations, but please note this is not comprehensive). Authors should contact their home institutions and funding organizations about options for assistance with open-access fees. Additionally, authors based at institutions with an Oxford University Press Open Access Prepayment Account can refer some or all of the charges associated with their manuscript to their institution’s prepayment account. Please read the OUP Open Access Prepayment Account for information about this program.
Author Self-Archiving/Public Access policy
For information about this journal's policy, please visit our Author Self-Archiving policy page.
Waiver Policies
Under SCAN’s fully open access model, the journal’s costs are now covered primarily by author publication charges (rather than subscription fees). Therefore, funds for waivers are very limited as the journal would not be sustainable without income from author charges to cover its costs. In particular, requests for waivers from authors with funding outlined at Funding sources for Article Processing Charges cannot be considered. SCAN hopes that contributors to the journal will support the open access model by paying the publication charges if they are able to do so.
Any waiver application must be authorised by a supporting applicant (e.g. Senior financial administrator or Head of Department). If it is impossible for you to pay the author processing charges outlined above, please contact the Publisher (via rhiannon.meaden@oup.com) stating the reason for the waiver application, the manuscript concerned, the name and email address of a supporting applicant and a concise supporting statement from that person.
Please also refer to the 'Resources' section above for guidance on paying open access fees.
Types of manuscript
SCAN will consider research that uses neuroimaging (fMRI, MRI, PET, EEG, MEG), neuropsychological patient studies, animal lesion studies, single-cell recording, pharmacological perturbation, and transcranial magnetic stimulation. SCAN will also consider submissions that examine the mediational role of neural processes in linking social phenomena to physiological, neuroendocrine, immunological, developmental, and genetic processes. Additionally, SCAN will publish papers that address issues of mental and physical health as they relate to social and affective processes (e.g., autism, anxiety disorders, depression, stress, effects of child rearing) as long as cognitive neuroscience methods are used.
SCAN is now also pleased to accept review papers and meta-analysis articles. Please submit via the online system or contact the Editor-in-Chief to discuss your idea first if preferred.
Letters to the Editor may be invited by the Editor-in-Chief to facilitate specific discussions around published content in the journal. Readers should contact the Editor-in-Chief prior to submitting a Letter to the Editor.
Finally, although SCAN aims to publish the best cutting research, its goal is also to be accessible to social scientists who do not themselves employ neuroscience techniques. To this end, studies should be described in language that makes their implications for the social sciences clear. We accept both empirical and review manuscripts. For empirical submissions, the maximum word limit is 5,000 words of text (not including references). For reviews, the maximum word limit is 10,000 words of text. There are facilities for publishing data on the Internet (e.g. additional tables, graphics and other material useful for enhancing the understanding of the manuscript) as supplementary data, which would not be subject to these length constraints (see also below).
The Editor-in-Chief can be reached via e-mail: lieber@ucla.edu or at the address below:
Matthew D. Lieberman, Ph.D.
Assistant Professor of Psychology
Franz Hall
University of California, Los Angeles
Los Angeles, CA 90095-1563
USA
Telephone: +1 310 206 4050
Fax: +1 310 206 5895
Preparation of manuscripts
Manuscripts should be in an editable file format such as .doc and should be double-spaced, including text, tables, legends and references. The full address, telephone and fax numbers of the corresponding author should appear on the title page. In addition to the full title of the paper, which should not exceed 100 characters including spaces, authors should supply a running title which will appear at the heads of the pages. This should not exceed 40 characters, including spaces. An abstract, not exceeding 200 words, followed by appropriate keywords up to a maximum of five, to appear at the beginning of the paper, should also be provided. The total number of words in the text (excluding references, tables and figure legends) should also be indicated.
References should be listed at the end of the paper in alphabetical order and not numbered. For multiple publications by the same author, those by the author alone are listed first, those with two authors listed after these and any with three or more authors must be given up to a maximum of six and any more should be indicated by et al. If there is more than one paper for a given year, these should be listed a, b, c, etc.
Barkovich, A. J. (1994) Disorders of neuronal migration and organization. In: R. I. Kuzniecky, G. D. Jackson (eds). Magnetic resonance in epilepsy. New York: Raven Press. p. 235-55.
Bushby, K. M. D., & Gardner-Medwin, D. (1993) The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy. I. Natural history. Journal of Neurology, 240, 98-104.
Costa, D. C., Morgan, G. F., & Lassen, N. A., editors. (1993) New trends in neurology and psychiatry. London: John Libbey.
Handwerker, H. O., & Kobal, G. (1993) Psychophysiology of experimentally induced pain. Physiology Review, 73, 639-71.
In the text, the author's name and year of publication are given in parentheses. If there are three or more authors, the name of the first is followed by et al. References to papers 'in press' must give the name of the journal or book. Reference citations should not include 'personal communications' or other inaccessible information; information derived from personal communications or from unpublished work by the authors should be referred to in the text.
In the online version of SCAN, there are automatic links from the reference section of each article to cited articles in Medline. This is a useful feature for readers, but is only possible if the references are accurate. It is the responsibility of the author to ensure the accuracy of the references in the submitted article. Downloading references direct from Medline is highly recommended.
Note : If your manuscript has previously been submitted elsewhere and already meets the word limits for SCAN, you may submit the manuscript as is, without reformatting it for SCAN. Although SCAN will not have a supplementary methods section, you can include the supplementary methods from a previous submission with your submission to SCAN. In the event that your article is accepted for publication in SCAN, you will be asked to reformat the article to be consistent with SCAN formatting standards.
SCAN participates in a uniform requirement agreement on submission of manuscripts (International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to Biomedical Journals. BMJ 1988; 296 : 401-405).
Suggesting reviewers . Please also include the names of 3-5 individuals that are qualified to review your manuscript. Indicate the name, institition and email address of each individual. We will try to have at least one reviewer from the set that you have requested. You may also request a member of the editorial team that you think is best suited to handle your manuscript.
The acceptance criteria for a manuscript are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are single-blind peer reviewed by at least two anonymous reviewers and an Associate Editor. Final acceptance or rejection rests with the Editorial Board, who reserves the right to refuse any material for publication.
Figures should be supplied in an electronic format at a suitable size for printing with the following resolutions: 600 dots per inch (dpi) for line drawings and combinations; 300 dpi for greyscale and colour. Colour figures must be supplied in CMYK not RGB colours. All figures submitted in colour will be freely published in the online version of SCAN in colour. Please note that all labels used in figures should be in upper case in both the figure and the legend. The journal reserves the right to reduce the size of illustrative material. All micrographs must carry a magnification bar.
Legends for figures should be listed on a separate sheet. All tables must bear a title. Footnotes may be used in the tables but not in the text.
Abbreviations for scientific units should conform to the Systeme Internationale (SI units). The statistical guidelines advocated by the International Committee of Medical Journal Editors (Ann Intern Med 1988; 108: 266-73) should be followed.
Availability of Data and Materials
Where ethically feasible, SCAN strongly encourages authors to make all data and software code on which the conclusions of the paper rely available to readers. We suggest that data be presented in the main manuscript or additional supporting files, or deposited in a public repository whenever possible. For information on general repositories for all data types, and a list of recommended repositories by subject area, please see Choosing where to archive your data.
Data Citation
SCAN supports the Force 11 Data Citation Principles and requires that all publicly available datasets be fully referenced in the reference list with an accession number or unique identifier such as a digital object identifier (DOI). Data citations should include the minimum information recommended by DataCite:
[dataset]* Authors, Year, Title, Publisher (repository or archive name), Identifier
*The inclusion of the [dataset] tag at the beginning of the citation helps us to correctly identify and tag the citation. This tag will be removed from the citation published in the reference list.
ORCID
SCAN requires submitting authors to provide an ORCID iD at submission to the journal. More information on ORCID and the benefits of using an ORCID iD is available. If you do not already have an ORCID iD, you can register for free via the ORCID website.
Preprint policy
Authors retain the right to make an Author’s Original Version (preprint) available through various channels, and this does not prevent submission to the journal. For further information see our Online Licensing, Copyright and Permissions policies. If accepted, the authors are required to update the status of any preprint, including your published paper’s DOI, as described on our Author Self-Archiving policy page.
Supplementary material
Supporting material that is not essential for inclusion in the full text of the manuscript, but would nevertheless benefit the reader, can be made available by the publisher as online-only content, linked to the online manuscript. The material should not be essential to understanding the conclusions of the paper, but should contain data that is additional or complementary and directly relevant to the article content. Such information might include more detailed methods, extended data sets/data analysis, or additional figures (including colour).
It is standard practice for appendices to be made available online-only as supplementary material. All text and figures must be provided in suitable electronic formats. All material to be considered as Supplementary material must be submitted at the same time as the main manuscript for peer review. It cannot be altered or replaced after the paper has been accepted for publication, and will not be edited. Please indicate clearly the material intended as Supplementary material upon submission. Also ensure that the Supplementary material is referred to in the main manuscript where necessary, for example as '(see Supplementary material)' or '(see Supplementary Figure 1)'.
Ethics issues
Authors should observe high standards with respect to publication best practice. Falsification or fabrication of data, plagiarism, including duplicate publication of the authors’ own work without proper citation, and misappropriation of work are all unacceptable practices. Any cases of ethical or publication malpractice are treated very seriously and will be managed in accordance with the Commission on Publication Ethics (COPE) guidelines.
Further information about OUP’s ethical policies is available on the Oxford ethics page.
Papers reporting experiments on patients or healthy volunteers must record the fact that the subjects' consent was obtained according to the Declaration of Helsinki (1991; p. 1194) and that the Ethical Committee of the Institution in which the work was performed has approved it. Consent must be also recorded when photographs of patients are shown or other details are given which could lead to the identification of the individuals. Experiments with animals should be performed in accordance with the legal requirements of the relevant local or national authority and the name of the authorizing body should be stated in the paper.
Procedures should be such that experimental animals do not suffer unnecessarily. The text of the paper should include experimental details of the procedure and of anaesthetics used. We encourage authors to follow the published ARRIVE reporting guidelines for studies involving animals. The Editorial Board reserves the right to reject papers where the ethical aspects are, in the board's opinion, open to doubt.
Authorship
All persons designated as authors should qualify for authorship. The order of authorship should be a joint decision of the co-authors. Each author should have participated sufficiently in the work to take public responsibility for the content. Authorship credit should be based on substantial contribution to conception and design, execution, or analysis and interpretation of data. All authors should be involved in drafting the article or revising it critically for important intellectual content, and must have read and approved the final version of the manuscript. Assurance that all authors of the paper have fulfilled these criteria for authorship should be given in the covering letter.
Funding & NIH Funding
Details of all funding sources for the work in question should be given in a separate section entitled 'Funding'. This should appear before the 'Acknowledgements' section.
The following rules should be followed:
Oxford Journals will deposit all NIH-funded articles in PubMed Central. See http://www.oxfordjournals.org/for_authors/repositories.htmlfor details. Authors must ensure that manuscripts are clearly indicated as NIH-funded using the guidelines below.
An example is given here: ‘This work was supported by the National Institutes of Health [AA123456 to C.S., BB765432 to M.H.]; and the Alcohol & Education Research Council [hfygr667789].
The sentence should begin: ‘This work was supported by …’
The full official funding agency name should be given, i.e. ‘National Institutes of Health’, not ‘NIH’ (full RIN-approved list of UK funding agencies) Grant numbers should be given in brackets as follows: ‘[grant number xxxx]’
Multiple grant numbers should be separated by a comma as follows: ‘[grant numbers xxxx, yyyy]’
Agencies should be separated by a semi-colon (plus ‘and’ before the last funding agency)
Where individuals need to be specified for certain sources of funding the following text should be added after the relevant agency or grant number 'to [author initials]'.
Conflict of interest
At the point of submission, SCAN’s policy requires that each author reveal any financial interests or connections, direct or indirect, or other situations that might raise the question of bias in the work reported or the conclusions, implications, or opinions stated - including pertinent commercial or other sources of funding for the individual author(s) or for the associated department(s) or organization(s), personal relationships, or direct academic competition. When considering whether you should declare a conflicting interest or connection please consider the conflict of interest test: Is there any arrangement that would embarrass you or any of your co-authors if it was to emerge after publication and you had not declared it?
As an integral part of the online submission process, Corresponding authors are required to confirm whether they or their co-authors have any conflicts of interest to declare, and to provide details of these. If the Corresponding author is unable to confirm this information on behalf of all co-authors, the authors in question will then be required to submit a completed Conflict of Interest form to the Editorial Office. It is the Corresponding author’s responsibility to ensure that all authors adhere to this policy.
If the manuscript is published, Conflict of Interest information will be communicated in a statement in the published paper.
Drug disclaimer
The mention of trade names, commercial products or organizations, and the inclusion of advertisements in the journal does not imply endorsement by the Editor-in-Chief, the editorial board, Oxford University Press or the organization to which the authors are affiliated. The Editor-in-Chief and publishers have taken all reasonable precautions to verify drug names and doses, the results of experimental work and clinical findings published in the journal. The ultimate responsibility for the use and dosage of drugs mentioned in the Journal and in interpretation of published material lies with the medical practitioner, and the editors and publishers cannot accept liability for damages arising from any errors or omissions in the journal. Please inform the editors of any errors.
Disclaimer
Statements of fact and opinion in the articles in SCAN are those of the respective authors and contributors and not of SCAN or Oxford University Press. Neither Oxford University Press nor SCAN make any representation, express or implied, in respect of the accuracy of the material in this journal and cannot accept any legal responsibility or liability for any errors or omissions that may be made. The reader should make his/her own evaluation as to the appropriateness or otherwise of any experimental technique described.
Copyright
It is a condition of publication in the Journal that authors grant an exclusive licence to the Journal, published by Oxford University Press. This ensures that requests from third parties to reproduce articles are handled efficiently and consistently and will also allow the article to be as widely disseminated as possible. In assigning the licence, authors may use their own material in other publications provided that the Journal is acknowledged as the original place of publication, and Oxford University Press is notified in writing and in advance.
Upon receipt of accepted manuscripts at Oxford Journals authors will be invited to complete an online copyright licence to publish form.
More Information about the New Creative Commons Licence.
Third-Party Content in Open Access papers
When you publish your paper under an Open Access licence and are aware it contains material for which you do not have Open Access re-use permissions, please state this clearly by supplying the following credit line alongside the material:
Title of content
Author, Original publication, year of original publication, by permission of [rights holder]
This image/content is not covered by the terms of the Creative Commons licence of this publication. For permission to reuse, please contact the rights holder.
Pre-Submission Language Editing
If your first language is not English, language editing to ensure that the academic content of your paper is fully understood by journal editors and reviewers is optional. Language editing does not guarantee that your manuscript will be accepted for publication. Authors are liable for all costs associated with such services.
Crossref Funding Data Registry
In order to meet your funding requirements authors are required to name their funding sources, or state if there are none, during the submission process.
Further information on this process and the CHORUS initiative.
SCAN encourages authors to make available all data pertaining to a published article should a request for such data be made.
Appeals and Complaints
Authors may appeal an Editor’s decision by contacting the Editor-in-Chief via email: lieber@ucla.edu. Authors should include as much detail as possible to explain the grounds of their appeal based on scientific evidence available.
Complaints, or concerns regarding published content in the journal should be addressed to the Editor-in-Chief via email lieber@ucla.edu. Where appropriate, if a complaint cannot be dealt with directly by the Editor-in-Chief, readers/authors may contact the Editorial Office via email socafn.editorialoffice@oup.com. In some cases, where appropriate, the reader may be invited to submit a Letter to the Editor to facilitate post-publication discussion of an article.
